Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2022 16:00 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
May 02, 2022 10:25 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call at the 59th European Renal Association (ERA) Congress

Data on atrasentan to be presented in an oral presentation from the IgA nephropathy (IgAN) patient cohort of the phase 2 AFFINITY basket trialUpdated data to be presented from Cohort 1 of Part 3 of...
April 25, 2022 16:05 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

SEATTLE, April 25, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
April 12, 2022 08:00 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Announces Initiation of Phase 1 Healthy Volunteer Trial of CHK-336, a First-in-Class LDHA Inhibitor to Treat Hyperoxalurias

SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
April 05, 2022 16:05 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
April 05, 2022 08:00 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and Care

SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy Foundation and Komodo Health today announced an outreach initiative leveraging data and...
March 21, 2022 08:15 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors

SEATTLE, March 21, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
March 17, 2022 16:00 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
March 08, 2022 16:05 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics to Present at Oppenheimer’s 32nd Annual Healthcare Conference

SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
February 22, 2022 08:15 ET | Source: Chinook Therapeutics, Inc.

Chinook Therapeutics Announces Upcoming Presentations at 4th Annual Chronic Kidney Disease Drug Development Summit

SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right